Recruiting studies: High Risk Localized Soft Tissue Sarcoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · 202 location(s) · National Cancer Institute (NCI) · NCT05691478 The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue Sarcoma
Phase 1/Phase 2 · 1 location(s) · Fudan University · NCT05774275 The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma
Phase 1/Phase 2 · 1 location(s) · Fudan University · NCT05839275 HIFU Ablation of Soft Tissue Sarcoma
NA · 1 location(s) · Oxford University Hospitals NHS Trust · NCT05111964 Sequential Neoadjuvant Chemotherapy in Soft Tissue Sarcoma
Phase 2 · 2 location(s) · Oslo University Hospital · NCT04776525 Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma
Phase 3 · 19 location(s) · Institut Claudius Regaud · NCT04307277

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.